Published in Proteomics on July 01, 2008
Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry. Anal Chem (2011) 1.23
The emerging process of Top Down mass spectrometry for protein analysis: biomarkers, protein-therapeutics, and achieving high throughput. Mol Biosyst (2010) 1.16
Progress in Top-Down Proteomics and the Analysis of Proteoforms. Annu Rev Anal Chem (Palo Alto Calif) (2016) 0.94
Developing top down proteomics to maximize proteome and sequence coverage from cells and tissues. Curr Opin Chem Biol (2013) 0.85
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
Histone demethylation by a family of JmjC domain-containing proteins. Nature (2005) 10.36
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev (2003) 4.93
Protein identification using sequential ion/ion reactions and tandem mass spectrometry. Proc Natl Acad Sci U S A (2005) 3.77
Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics (2009) 3.65
Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24
Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med (2012) 3.03
A human proteome detection and quantitation project. Mol Cell Proteomics (2009) 2.80
Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development (2003) 2.78
The rate of hydrolysis of phosphomonoester dianions and the exceptional catalytic proficiencies of protein and inositol phosphatases. Proc Natl Acad Sci U S A (2003) 2.76
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics (2005) 2.71
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol (2012) 2.54
Catalytic proficiency: the unusual case of OMP decarboxylase. Annu Rev Biochem (2001) 2.48
The ribosome as an entropy trap. Proc Natl Acad Sci U S A (2004) 2.40
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. Biotechniques (2002) 2.25
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther (2005) 2.20
Cell autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal fusion. Dev Biol (2006) 1.79
The time required for water attack at the phosphorus atom of simple phosphodiesters and of DNA. Proc Natl Acad Sci U S A (2006) 1.78
Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother (2011) 1.64
Crosslinking combined with mass spectrometry for structural proteomics. Mass Spectrom Rev (2010) 1.63
Phosphorylation of stem-loop binding protein (SLBP) on two threonines triggers degradation of SLBP, the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Mol Cell Biol (2003) 1.61
Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP signaling during tooth and palate development. Dev Cell (2008) 1.61
Molecular typing of Salmonella enterica serovar typhi isolates from various countries in Asia by a multiplex PCR assay on variable-number tandem repeats. J Clin Microbiol (2003) 1.58
A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J Proteome Res (2010) 1.58
Combined deficiencies of Msx1 and Msx2 cause impaired patterning and survival of the cranial neural crest. Development (2005) 1.52
Equilibrium of formation of the 6-carbanion of UMP, a potential intermediate in the action of OMP decarboxylase. J Am Chem Soc (2002) 1.50
Histone variant H2ABbd confers lower stability to the nucleosome. EMBO Rep (2004) 1.49
A systems-biology analysis of feedback inhibition in the Sho1 osmotic-stress-response pathway. Curr Biol (2007) 1.47
Diagnosis of heart failure with preserved ejection fraction: which parameters and diagnostic strategies are more valuable? Eur J Heart Fail (2011) 1.46
Acute cardiovascular effects of the Wenchuan earthquake: ambulatory blood pressure monitoring of hypertensive patients. Hypertens Res (2009) 1.46
HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol (2013) 1.45
A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol (2009) 1.41
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics (2007) 1.41
The burden borne by urease. J Am Chem Soc (2005) 1.40
MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics (2012) 1.35
Hydrogen/deuterium exchange mass spectrometry with top-down electron capture dissociation for characterizing structural transitions of a 17 kDa protein. J Am Chem Soc (2009) 1.35
H2A.Z stabilizes chromatin in a way that is dependent on core histone acetylation. J Biol Chem (2006) 1.33
An isotopically coded CID-cleavable biotinylated cross-linker for structural proteomics. Mol Cell Proteomics (2010) 1.31
Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health (2008) 1.30
Isotopically coded cleavable cross-linker for studying protein-protein interaction and protein complexes. Mol Cell Proteomics (2005) 1.29
Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest (2007) 1.29
High-density single-nucleotide polymorphism maps of the human genome. Genomics (2005) 1.27
Electron capture dissociation of electrosprayed protein ions for spatially resolved hydrogen exchange measurements. J Am Chem Soc (2008) 1.25
Mnd2 and Swm1 are core subunits of the Saccharomyces cerevisiae anaphase-promoting complex. J Biol Chem (2003) 1.24
Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys (2006) 1.23
The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One (2011) 1.21
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension. Clin Pharmacol Ther (2004) 1.20
Combined top-down and bottom-up proteomics identifies a phosphorylation site in stem-loop-binding proteins that contributes to high-affinity RNA binding. Proc Natl Acad Sci U S A (2006) 1.20
H2A.Z and H3.3 histone variants affect nucleosome structure: biochemical and biophysical studies. Biochemistry (2009) 1.19
LEF1 is a critical epithelial survival factor during tooth morphogenesis. Dev Biol (2005) 1.17
Acetylation of vertebrate H2A.Z and its effect on the structure of the nucleosome. Biochemistry (2009) 1.17
BiPS, a photocleavable, isotopically coded, fluorescent cross-linker for structural proteomics. Mol Cell Proteomics (2008) 1.17
Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res (2007) 1.17
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc Natl Acad Sci U S A (2006) 1.16
Catalytic proficiency: the extreme case of S-O cleaving sulfatases. J Am Chem Soc (2011) 1.15
Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis (2010) 1.14
ICC-CLASS: isotopically-coded cleavable crosslinking analysis software suite. BMC Bioinformatics (2010) 1.14
Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol (2008) 1.14
Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics (2010) 1.14
The effective molarity of the substrate phosphoryl group in the transition state for yeast OMP decarboxylase. Bioorg Chem (2005) 1.13
The evolutionary differentiation of two histone H2A.Z variants in chordates (H2A.Z-1 and H2A.Z-2) is mediated by a stepwise mutation process that affects three amino acid residues. BMC Evol Biol (2009) 1.12
Impact of salmonella infection on host hormone metabolism revealed by metabolomics. Infect Immun (2011) 1.12
Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics (2008) 1.12
Rates of spontaneous disintegration of DNA and the rate enhancements produced by DNA glycosylases and deaminases. Biochemistry (2007) 1.11
Phosphorylation of paxillin by p38MAPK is involved in the neurite extension of PC-12 cells. J Cell Biol (2004) 1.11
The rate enhancement produced by the ribosome: an improved model. Biochemistry (2007) 1.11
3' end processing of Drosophila melanogaster histone pre-mRNAs: requirement for phosphorylated Drosophila stem-loop binding protein and coevolution of the histone pre-mRNA processing system. Mol Cell Biol (2002) 1.10
The first pilot project of the consortium for top-down proteomics: a status report. Proteomics (2014) 1.08
Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis. Proteomics Clin Appl (2007) 1.08
In vivo growth of porcine reproductive and respiratory syndrome virus engineered nsp2 deletion mutants. Virus Res (2010) 1.08
The intrinsic reactivity of ATP and the catalytic proficiencies of kinases acting on glucose, N-acetylgalactosamine, and homoserine: a thermodynamic analysis. J Biol Chem (2009) 1.08
A comparison of MS/MS-based, stable-isotope-labeled, quantitation performance on ESI-quadrupole TOF and MALDI-TOF/TOF mass spectrometers. Proteomics (2009) 1.07
Mass-spectrometry-based clinical proteomics--a review and prospective. Analyst (2010) 1.06
Comment on "Profiling oil sands mixtures from industrial developments and natural groundwaters for source identification". Environ Sci Technol (2014) 1.06
Comparison study on clinical and neuropathological characteristics of hamsters inoculated with scrapie strain 263K in different challenging pathways. Biomed Environ Sci (2004) 1.04
An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis. Anal Chim Acta (2007) 1.03
Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension. J Am Soc Mass Spectrom (2010) 1.03
MeCP2 binds to nucleosome free (linker DNA) regions and to H3K9/H3K27 methylated nucleosomes in the brain. Nucleic Acids Res (2011) 1.03
Multi-kinase phosphorylation of the APC/C activator Cdh1 revealed by mass spectrometry. Cell Cycle (2004) 1.03
Spatial differences in an integral membrane proteome detected in laser capture microdissected samples. J Proteome Res (2008) 1.03
Inhibition of APCCdh1 activity by Cdh1/Acm1/Bmh1 ternary complex formation. J Biol Chem (2006) 1.02
Familial CJD associated PrP mutants within transmembrane region induced Ctm-PrP retention in ER and triggered apoptosis by ER stress in SH-SY5Y cells. PLoS One (2011) 1.02
Identification of two small regulatory RNAs linked to virulence in Brucella abortus 2308. Mol Microbiol (2012) 1.01
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics (2013) 1.01
Orotic acid decarboxylation in water and nonpolar solvents: a potential role for desolvation in the action of OMP decarboxylase. Biochemistry (2009) 1.01